Science Secures $400 Million In Series D Funding To Expand Brain-Computer Interface Program
Science has raised $400 million in a Series D funding round at a $3.5 billion valuation, with participation from Khosla Ventures , the Ackman Oxman Institute, Tenet Healthcare , 885 Capital, Y Combinator and PLC Neuro…
Science has raised $400 million in a Series D funding round at a $3.5 billion valuation, with participation from Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech, among others. The funding brings its total capital raised since its 2021 founding to more than $900 million and will support the European expansion of PRIMA, its brain-computer interface designed to restore form vision in patients with certain types of late-stage macular degeneration, its planned U.S. launch pending FDA approval, and further investments in research, manufacturing and its biohybrid neural interface program.
FOUNDER: Max Hodak
INVESTORS: Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, PLC Neurotech
ROUND: Series D AMOUNT: $400,000,000 VALUATION: $3,500,000,000
HQ: Alameda, California
#VentureCapital #Science #MaxHodak #KhoslaVentures #TradedVC
ABOUT THE DEAL
- Raise
- $400M
- Round
- Series D
- Company
- Science
- Desk
- Deals
- Filed
- Nov 18, 2026
- Founders
- Max Hodak
- Investors
- Khosla Ventures
- Ackman Oxman Institute
- Tenet Healthcare
- 885 Capital
- Y Combinator
- PLC Neurotech
More deals
ALL DEALSGenesis AI Secures $500 Million In Series A Funding Led By Premji Invest And Khosla Ventures
Nov 18, 2026
August Labs Inc. Secures $12 Million In Seed Funding From Peak XV And Accel
Nov 17, 2026
Tiberius Aerospace Secures $85 Million In Series A Funding To Boost Defense Technology Development
Nov 17, 2026